1-14 of 14
Samira Zeynalova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of a Prognostic Model to Assess the Risk of CNS Disease in Patients with Aggressive B-Cell Lymphoma

Kerry J. Savage, MDMSc, Samira Zeynalova, PhD, Roopesh R. Kansara, MD, Maike Nickelsen, MD, Diego Villa, MDMPH, Laurie H. Sehn, MDMPH, Marita Ziepert, David W. Scott, MBChB, PhD, Michael Pfreundschuh, MD PhD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Bertram Glass, MD, Markus Loeffler, Prof MDPhD, Norbert Schmitz
Journal: Blood
Blood (2014) 124 (21): 394.
https://doi.org/10.1182/blood.V124.21.394.394
Published: 2014
Journal Articles

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

Clinical Trials & Observations
Niels Murawski, Gerhard Held, Marita Ziepert, Barbara Kempf, Andreas Viardot, Mathias Hänel, Mathias Witzens-Harig, Rolf Mahlberg, Christian Rübe, Jochen Fleckenstein, Carsten Zwick, Bertram Glass, Norbert Schmitz, Samira Zeynalova, Michael Pfreundschuh
Journal: Blood
Blood (2014) 124 (5): 720–728.
https://doi.org/10.1182/blood-2013-10-535021
Published: 2014
Includes: Supplemental data
Journal Articles

Suboptimal dosing of rituximab in male and female patients with DLBCL

Clinical Trials & Observations
Michael Pfreundschuh, Carsten Müller, Samira Zeynalova, Evelyn Kuhnt, Martin H. J. Wiesen, Gerhard Held, Tanja Rixecker, Viola Poeschel, Carsten Zwick, Marcel Reiser, Norbert Schmitz, Niels Murawski
Journal: Blood
Blood (2014) 123 (5): 640–646.
https://doi.org/10.1182/blood-2013-07-517037
Published: 2014
Includes: Supplemental data
Journal Articles

The Impact of Rituximab and Radiotherapy On Treatment Outcome of Patients with DLBCL and Skeletal Involvement

Gerhard Held, MD, Samira Zeynalova, PhD, Niels Murawski, MD, Marita Ziepert, PhD, Barbara Kempf, MD, Andreas Viardot, MD, Martin Dreyling, Michael Hallek, MD, Mathias Witzens-Harig, MD, Christian Ruebe, MD, Christian Berdel, MD, Carsten Zwick, MD, Norbert Schmitz, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2012) 120 (21): 690.
https://doi.org/10.1182/blood.V120.21.690.690
Published: 2012
Journal Articles

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Clinical Trials & Observations
Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser
Journal: Blood
Blood (2012) 119 (14): 3276–3284.
https://doi.org/10.1182/blood-2011-09-380949
Published: 2012
Journal Articles

Improved Outcome of Elderly Poor-Prognosis DLBCL Patients with 6xCHOP-14 and 8 Applications of Rituximab (R) Given Over An Extended Period: Results of the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Michael Pfreundschuh, MD, Gerhard Held, Samira Zeynalova, Viola Pöschel, Andreas Viardot, MD, Matthias Hänel, MD, Ulrich Keller, MD, Marcel Reiser, MD, Markus Löffler, Niels Murawski, MD
Journal: Blood
Blood (2011) 118 (21): 592.
https://doi.org/10.1182/blood.V118.21.592.592
Published: 2011
Journal Articles

CNS Disease In Younger Patients (<=60 years) with Aggressive Lymphoma Treated In Trials of the German High Grade Non Hodgkin Lymphoma Study Group (DSHNHL) and the MabThera International Trial (MInT)

Norbert Schmitz, MD, Samira Zeynalova, Bertram Glass, MD, Ulrich Kaiser, MD, Eva Cavallin-Stahl, MD, Max Wolf, MBBS, FRACP, FRCPA, Mathias Haenel, MD, Markus Loeffler, MD, Lorenz Trümper, MD, M. Pfreundschuh
Journal: Blood
Blood (2010) 116 (21): 112.
https://doi.org/10.1182/blood.V116.21.112.112
Published: 2010
Journal Articles

Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Viola Poeschel, Marcel Reiser, Anthony D. Ho, Christina Nickenig, Swen Wessendorf, Bernd Metzner, Sandra Grass, Joerg Schubert, Markus Loeffler, Norbert Schmitz
Journal: Blood
Blood (2009) 114 (22): 3715.
https://doi.org/10.1182/blood.V114.22.3715.3715
Published: 2009
Journal Articles

Response:Intrathecal methotrexate and central nervous system events

Norbert Schmitz, Samira Zeynalova, Markus Loeffler, Michael Pfreundschuh, German High Grade Lymphoma Study Group
Journal: Blood
Blood (2009) 114 (9): 1999–2000.
https://doi.org/10.1182/blood-2009-06-226076
Published: 2009
Journal Articles

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Clinical Trials & Observations
Volkmar Boehme, Norbert Schmitz, Samira Zeynalova, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2009) 113 (17): 3896–3902.
https://doi.org/10.1182/blood-2008-10-182253
Published: 2009
Journal Articles

CNS-Disease in Elderly Patients Treated with Modern Chemotherapy (CHOP-14) with or without Rituximab: An Analysis of CNS Events in the RICOVER-60 Trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL).

Volkmar Boehme, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Marcel Reiser, MD, Hans Steinhauer, MD, Michael Clemens, MD, Christine Nickenig, MD, Maike de Witt, MD, Markus Loeffler, MD, Michael Pfreundschuh, MD, Norbert Schmitz, MD
Journal: Blood
Blood (2007) 110 (11): 519.
https://doi.org/10.1182/blood.V110.11.519.519
Published: 2007
Journal Articles

Dose-Dense Rituximab Improves Outcome of Elderly Patients with Poor-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Samira Zeynalova, Viola Poeschel, Mathias Haenel, PD, Norbert Schmitz, Manfred Hensel, PD, Marcel Reiser, PD, Markus Loeffler, Joerg Schubert
Journal: Blood
Blood (2007) 110 (11): 789.
https://doi.org/10.1182/blood.V110.11.789.789
Published: 2007
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005